Renee Lentini, VP & Principal Accounting OFFICER at ImmunoGen, Inc. (IMGN), sold 5,262 shares at $29.30 ($154K) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Scheduled sale ($154k) by VP & Principal Accounting OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.30 | 2,631 | $77K | 50.0% |
| 2 | $29.30 | 2,631 | $77K | 50.0% |
| Total | $29.30 avg | 5,262 | $154K | 100% |
| Filing → |
| IMGN | SELL | 2023-08-04 | $5.2M | — | Filing → |